Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-12-23

FDA Approved: PIROXICAM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva's supplemental application for Piroxicam (PIROXICAM). This is a supplemental approval affecting the PIROXICAM product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Piroxicam (piroxicam)

Snippet

SUPPL AP for PIROXICAM (PIROXICAM)